Ask AI

Increasing Survival in Stage III NSCLC: Optimizing Care and Addressing New Clinical Challenges

In this online program experts discuss recent advances in the use of immunotherapy to optimize outcomes in patients with stage III NSCLC. Watch the on-demand Webcast and download the slides from a dynamic CCO symposium at the 2019 SITC Annual Meeting to learn more about how to integrate immunotherapies into your clinical practice.

Share

Program Content

Activities

Immunotherapy for Stage I-III NSCLC
Immunotherapy in Stage III and Earlier Stage NSCLC: Optimizing Care Today and Tomorrow
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2019

Expires: November 06, 2020

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca